A tissue-scale strategy for sensing threats in barrier organs
Cell Systems · 2026-07 · 17 (7) · 101611
DOI: 10.1016/j.cels.2026.101611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2026-07. Verfasst von Diep H Nguyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Whitehead Institute for Biomedical Resear…. Hauptthemen laut MEDLINE: Innate Immunity Recognition, Receptors, Pattern Recognition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: NICHD NIH HHS, National Cancer Institute, Allen Family Philanthropies.
Abstract (Originalsprache)
Barrier organs rely on a limited set of pattern recognition receptors (PRRs) to detect diverse immunogenic challenges. How these organs assess threats and adjust immune responses to balance host protection with collateral damage remains unclear. Here, by characterizing the probability of detecting influenza infection across different cell types in the lung using single-molecule imaging and spatial transcriptomics, we discovered cell-type-specific probabilities of threat sensing: lowest in the epithelia and highest in the stroma. Such differential probabilities emerge from spatially graded expression of nucleic acid-sensing PRRs across lung tissue compartments, a strategy widely adopted by barrier organs. Selectively increasing the level of retinoic acid-inducible gene I (RIG-I) in lung epithelia in vivo exacerbates tissue damage upon non-infectious challenge, revealing the importance of dampening the sensitivity of barrier epithelia. Together, these results highlight a spatially tiered strategy to tolerate epithelia-restricted threats and yet enable progressively potent immune responses as threats invade deeper into the tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA.
- David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and…
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA. Electronic address: pli@wi.mit.edu.
Förderung
- NICHD NIH HHS
- National Cancer Institute
- Allen Family Philanthropies
- National Institutes of Health
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Merkin Institute for Translational Research, California Institute of Technology
- Searle Scholars Program
- Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
Zitieren
APA
Nguyen, D. H., Tian, J., Shanahan, S. L., Wang, C. K., Jacks, T., Wang, X., & Li, P. (2026). A tissue-scale strategy for sensing threats in barrier organs. Cell Systems, 17(7), 101611. https://doi.org/10.1016/j.cels.2026.101611
Vancouver
Nguyen DH, Tian J, Shanahan SL, Wang CK, Jacks T, Wang X, et al. A tissue-scale strategy for sensing threats in barrier organs. Cell Systems. 2026;17(7):101611. doi:10.1016/j.cels.2026.101611
BibTeX
@article{Nguyen2026,
author = {Nguyen, Diep H and Tian, Jiakun and Shanahan, Sean-Luc and Wang, Connie Kangni and Jacks, Tyler and Wang, Xiao and Li, Pulin},
title = {A tissue-scale strategy for sensing threats in barrier organs},
journal = {Cell Systems},
year = {2026},
volume = {17},
number = {7},
pages = {101611},
doi = {10.1016/j.cels.2026.101611}
}
EUVIMED